Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Augusta
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Augusta, GA

Studies commonly pay $75 to $4,500 per completed study

182 clinical trials are currently recruiting participants within 30 miles of Augusta. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

182studies recruiting
5+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Augusta right now

Top 25 of 182 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Southeast Retina Center — Augusta, Georgia (9.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Augusta, Georgia (9.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)

Whole Body Vibration, Osteo Arthritis Knee N/A Interventional 30 participants sought
Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology — Augusta, Georgia (9.2 mi) · Sponsor: Augusta University
See eligibility & contact on ClinicalTrials.gov (NCT06058169)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 50 participants sought
Neurocrine Clinical Site — Augusta, Georgia (9.2 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07105111)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Palmetto Retina Center — Aiken, South Carolina (24.4 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07440225)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

HER2-negative Breast Cancer Patients With Brain Metastases Phase 2 Interventional 120 participants sought
Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Biostar Pharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06764940)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Pancreatic Cancer N/A Observational 500 participants sought
Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: University of Louisville
See eligibility & contact on ClinicalTrials.gov (NCT02674100)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma Phase 3 Interventional 421 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05976763)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Southeast Retina Center, P.C. — Augusta, Georgia (9.2 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)
Actively enrolling

Studies you may be able to join near Augusta

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Augusta

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Southeastern Clinical Research Institute

1521 Anthony Rd, Augusta, GA 30904
(706) 922-3005

Masters of Clinical Research

1232 Augusta W Pkwy, Augusta, GA 30909
(706) 210-8890

Telemedicine & Advanced Technology Research Center (TATRC) Digital Health Innovation Center (DHIC)

300 E Hospital Rd, Fort Gordon, GA 30905
(301) 619-7927

Georgia Prevention Institute

★ 4.8
1499 Walton Wy, Augusta, GA 30912
(706) 721-4534
"A place for and of exercise and health that lives up to the standard of pushing yourself. I am still sore."
— Richard Drake, 4★

Georgia Cancer Center - M. Bert Storey Research Building

★ 5.0
1410 Laney Walker Blvd, Augusta, GA 30912
(706) 721-0570
"Such professional caring care throughout all stages of care - from physicians to auxiliary medical care to clinic and infusion nurses to medical assi…"
— Genie Fulcher, 5★

Clinical trials in Augusta: what's recruiting

The Augusta area currently has 182 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Augusta, the most active research areas are:

  • Cancer & Oncology15 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies
  • Immune & Skin1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Augusta, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Augusta

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Augusta participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Augusta, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Augusta?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Augusta?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Augusta.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Augusta typically complete one or two studies per year.

Paid clinical trials near Augusta

Other metros within reach

Columbia, SC197 Athens, GA71 Mauldin, SC373 Greenville, SC373 Spartanburg, SC357 Savannah, GA169 Macon, GA73 Warner Robins, GA73

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Augusta Chronic Kidney Disease (HealthMatch) in Augusta Bladder Issues Due To Spinal Cord Injury in Augusta All conditions

More of GA

Atlanta1,693 Savannah169 Gainesville152 Macon73 Warner Robins73 Athens71 Columbus67

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts